Memphasys Share Price and Company Fundamentals
Last traded: 07/25/2022
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
|Primary activities||Memphasys Limited (ASX:MEM) specialises in biological separations for commercial applications. The Company's patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||30 Richmond Road Homebush NSW 2140 Australia|
|Phone / Fax||61 2 8415 7300 / 61 2 8415 7399|
|Share registry||BOARDROOM PTY LIMITED|
Memphasys paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MEM dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
MEM's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Aug 2022, following are the company executives and directors listed on Memphasys.
|Ms. Alison Mary Coutts B.E., B.E. (Chem), GDipBiotech, M.B.A., MBA||MD, CEO & Director||383.76k|
|Pablo Neyertz||Director of Fin.||158.26k|
|Nick Gorring||Operations Mang.||153.34k|
|Mr. Malcolm Coleman||Chief Financial Officer of Nusep Ltd|
|Mr. Andrew Metcalfe B.Bus, CPA, FGIA, MAICD||Company Sec.|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Memphasys is and its enterprise value is .
Companies similar to Memphasys (MEM)
Memphasys (ASX:MEM) Frequently Asked Questions
1. What is Memphasys's Stock Symbol?
Memphasys trades on ASX under the ticker symbol "MEM".
2. What is Memphasys's stock price today?
One share of MEM stock can currently be purchased for approximately $0.045.
3. How can I contact Memphasys?
Memphasys's mailing address is 30 Richmond Road Homebush NSW 2140 Australia. The company can be reached via phone at 61 2 8415 7300.
4. What is Memphasys's official website?
The official website of Memphasys is https://www.memphasys.com.
5. Which share registry manages Memphasys's stock?
Memphasys's stock is managed by BOARDROOM PTY LIMITED.